Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3EOB

Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form II

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsPHOTON FACTORY BEAMLINE BL-17A
Synchrotron sitePhoton Factory
BeamlineBL-17A
Temperature [K]100
Detector technologyCCD
Collection date2008-05-27
DetectorADSC QUANTUM 270
Wavelength(s)1.0000
Spacegroup nameP 61 2 2
Unit cell lengths111.096, 111.096, 470.726
Unit cell angles90.00, 90.00, 120.00
Refinement procedure
Resolution50.000 - 3.600
R-factor0.269
Rwork0.267
R-free0.33300
Structure solution methodMOLECULAR REPLACEMENT
RMSD bond length0.011
RMSD bond angle1.700
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareCNS
Refinement softwareCNS
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0003.730
High resolution limit [Å]3.6003.600
Rmerge0.2030.622
Number of reflections20645
<I/σ(I)>7.52
Completeness [%]97.898.9
Redundancy5.34.4
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP7.32770.1M sodium cacodylate, 0.2M zinc acetate, 11% w/v PEG 8000, pH 7.3, VAPOR DIFFUSION, HANGING DROP, temperature 277K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon